Trends in incidence of neonatal late-onset sepsis in very low birth weight infants: a 15-year Brazilian single center analysis
- PMID: 39982612
- DOI: 10.1007/s10096-025-05074-z
Trends in incidence of neonatal late-onset sepsis in very low birth weight infants: a 15-year Brazilian single center analysis
Abstract
Purpose: Multiresistant (MR) bacteria neonatal sepsis has been progressively increasing worldwide, raising the risk of death. This study aimed to evaluate the incidence of late-onset neonatal sepsis (LOS) and the incidence of MR agents in very low birth weight (VLBW) infants in a Brazilian tertiary neonatal unit over 15 years.
Methods: This was a retrospective temporal trend study. All VLBW infants admitted from 2006 to 2020 diagnosed with LOS caused by Staphylococcus aureus, Enterococcus spp or Gram-negative bacilli were eligible.
Results: During the period, 259/1,575 (16.4%) VLBW infants had confirmed LOS, corresponding to 311 episodes of sepsis, 114 of them by agents of interest. There were 20 episodes of MR bacteria LOS (6.4% of the total confirmed LOS), corresponding to 17.5% of the cases of LOS by the studied agents, and to an incidence of 12.7/1,000 admitted VLBW infants. There was a significant trend towards a reduction in the rate of confirmed LOS (P = 0.010), while the trend of incidence of MR agents' sepsis remained stable (1.3 episodes per year - range 0-4/year). The MR incidence corresponded to 18.4% for S. aureus and 19% for Gram-negative bacilli strains. There were no cases of MR Enterococcus or carbapenemase-producing organisms. The rate of sepsis-related in-hospital death was not statistically different between the MR and non-resistant sepsis groups (15.0 versus 19.1%, P = 1,000).
Conclusion: The incidence of confirmed LOS in VLBW infants has shown a downward trend, while the rate of LOS due to MR bacteria has remained low and stable over 15 years.
Keywords: Drug resistance, bacterial; Incidence; Infant, Very low birth weight; Neonatal sepsis; Observational study; Sepsis.
© 2025. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Conflict of interest statement
Declarations. Ethical approval: This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of the State University of Campinas. Consent to participate: The informed consent was waived by the Institutional Review Board since this was a retrospective analysis of existing clinical data. Consent to publish: The informed consent was waived by the Institutional Review Board since this was a retrospective analysis of existing clinical data. Competing interests: The authors declare no competing interests.
References
-
- Watkins RR, Bonomo RA (2016) Overview: global and local impact of Antibiotic Resistance. Infect Dis Clin North Am 30(2):313–322. https://doi.org/10.1016/j.idc.2016.02.001 - DOI - PubMed
-
- Murray CJL, Ikuta KS, Sharara F, Swetschinski L, Robles Aguilar G, Gray A et al (2022) Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet 399(10325):629–655 - DOI
-
- Cantey JB, Milstone AM (2015) Bloodstream infections: epidemiology and resistance. Clin Perinatol 42(1):1–16, vii. https://doi.org/10.1016/j.clp.2014.10.002
MeSH terms
Substances
LinkOut - more resources
Full Text Sources